Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy

ClinicalTrials.gov ID: NCT00547651

Public ClinicalTrials.gov record NCT00547651. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 1:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AMR PH GL 2007 CL001 Phase 3 A Randomized, Open-Label, Multinational Phase 3 Trial Comparing Amrubicin Versus Topotecan in Patients With Extensive or Limited and Sensitive or Refractory Small Cell Lung Cancer After Failure of First-Line Chemotherapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study drug (Amrubicin) is believed to work by stopping the tumor cells in your body from growing. The purpose of this study is to evaluate the effect of amrubicin compared to topotecan in the treatment of small cell lung cancer.

Study identification

NCT ID
NCT00547651
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Celgene
Industry
Enrollment
637 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 1, 2007 (Actual)
Primary completion
May 1, 2011 (Actual)
Completion
May 1, 2011 (Actual)
Last update posted
Nov 6, 2019

2007 – 2011

United States locations

U.S. sites
61
U.S. states
29
U.S. cities
60
Facility City State ZIP Site status
Northwest Alabama Cancer Center Muscle Shoals Alabama 35661 —
Arizona Oncology Associates Tucson Arizona 85704 —
Little Rock Hematology Oncology Associates Little Rock Arkansas 72205 —
Cancer Care Associates of Fresno Medical Group, Inc. Fresno California 93720 —
Cedars-Sinai Outpatient Cancer Center Los Angeles California 90048 —
University of Colorado Health Science Centre Aurora Colorado 80045 —
Rocky Mountain Cancer Center - Midtown (Main) Denver Colorado 80218 —
Advanced Medical Specialties Miami Florida 33176 —
Ocala Oncology Center Ocala Florida 34474 —
Cancer Centers of Florida, P.A. Ocoee Florida 34761 —
Florida Oncology Associates Orange Park Florida 32073 —
Sacred Heart Medical Oncology Pensacola Florida 32504 —
Medical Oncology Associates of Augusta Augusta Georgia 30809 —
Joliet Oncology-Hematology Associates, Ltd. Joliet Illinois 60435 —
Cancer & Hematology Specialists of Chicago (Main) Niles Illinois 60714 —
Illinois Cancer Care Peoria Illinois 61615 —
Cancer Care at Blessing Hospital Quincy Illinois 62301 —
Central Indiana Cancer Centers Indianapolis Indiana 46227 —
Hope Center Terre Haute Indiana 47802 —
Kansas City Cancer Center (Main) Overland Park Kansas 66210 —
Cancer Center of Kansas Wichita Kansas 67214 —
Jayne Gurtler MD, Laura Brizn MD, Angelo Russo MD, and Janet Burroff MD, APMC Metairie Louisiana 70006 —
Tulane University Health Sciences Center New Orleans Louisiana 70112 —
Maine Center for Cancer Medicine and Blood Disorders Scarborough Maine 04074 —
Sinai Hospital of Baltimore, Inc. Baltimore Maryland 21215 —
Center for Cancer and Blood Disorders Bethesda Maryland 20817 —
Alliance Hematology Oncology, P.A. (Main) Westminster Maryland 21157 —
Kalamazoo Hematology and Oncology Kalamazoo Michigan 49048 —
Michigan Hematology & Oncology Institute Southgate Michigan 48195 —
University of Minnesota Medical Center, Cancer Center Minneapolis Minnesota 55455 —
Missouri Cancer Associates Columbia Missouri 65201 —
St. Joseph Oncology, Inc. Saint Joseph Missouri 64507 —
Comprehensive Care Centers of Nevada (Main) Las Vegas Nevada 89169 —
New York Oncology Hematology, P.C. Latham New York 12110-0610 —
SUNY Upstate Medical University - Regional Oncology Center Syracuse New York 13210 —
Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 —
Regional Cancer Care Durham North Carolina 27704 —
Cancer Centers of North Carolina (Main) Raleigh North Carolina 27607 —
Piedmont Hematology Oncology Associates Winston-Salem North Carolina 27103 —
Gabrail Cancer Center Canton Ohio 44718 —
Greater Dayton Cancer Center (Main) Kettering Ohio 45409 —
Cancer Care Associates Oklahoma City Oklahoma 73112 —
Cancer Care Associates Tulsa Oklahoma 74136 —
Willamette Valley Cancer Center (Main) Eugene Oregon 97401-8122 —
Medical Oncology Associates Kingston Pennsylvania 18704 —
Thomas Jefferson Memorial Hospital Philadelphia Pennsylvania 19107 —
UPMC Cancer Pavilion Pittsburgh Pennsylvania 15232 —
Cancer Centers of the Carolinas (Main) Greenville South Carolina 29615 —
The Sarah Cannon Research Institute/TN Oncology Nashville Tennessee 37203 —
Texas Oncology, P.A. Amarillo Texas 79106 —
Coastal Bend Cancer Center Corpus Christi Texas 78463 —
Texas Cancer Center at Medical City (Main) Dallas Texas 75230-2510 —
Texas Oncology, P.A. (Main) Dallas Texas 75246 —
West Texas Cancer Center-Texas Oncology Odessa Texas 79761 —
Texas Oncology, P.A. Webster Texas 77598-4420 —
Texoma Cancer Center Wichita Falls Texas 76310 —
Fairfax Northern Virginia Hematology/Oncology Fairfax Virginia 22031 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Blue Ridge Cancer Care Roanoke Virginia 24019 —
Northwest Cancer Specialists - Vancouver (Main) Vancouver Washington 98684 —
Marshfield Clinic Marshfield Wisconsin 54449 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 79 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00547651, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 6, 2019 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00547651 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →